ArticleNature communications2025
Transient rapamycin treatment avoids unwanted host immune responses toward AAV-delivered anti-HIV antibodies.
Sebastian P Fuchs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it